VIEWS: 7 PAGES: 2 CATEGORY: DocStore POSTED ON: 1/25/2011
Derived from the saliva of ticks, and working by a totally different mechanism than common blood thinner warfarin (Coumadin), studies have been ongoing on two drugs, dabigatran (Pradaxa), a direct thrombin (factor X) inhibitor which was approved by the FDA last month for blood thinning stroke patients with atrial fibrillation, and rivaroxaban (Xarelto), a factor Xa inhibitor which seems to be on the verge of approval. Both of these new drugs are patient friendly, not requiring blood tests or a special diet.
Pages to are hidden for
"Antidote"Please download to view full document